Matinas BioPharma Inc. (MTNB)
AMEX: MTNB
· Real-Time Price · USD
2.31
0.66 (40.00%)
At close: Aug 15, 2025, 3:59 PM
2.42
4.99%
After-hours: Aug 15, 2025, 07:58 PM EDT
Matinas BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.66M | -8.43M | -4.28M | -5.72M | -5.82M | -5.31M | -6.05M | -6.06M | -5.51M | -3.63M | -5.46M | -5.92M | -5.98M | -6.7M | -6.84M | -4.79M | -4.96M |
Depreciation & Amortization | 127K | 247K | 240K | 241K | 240K | 240K | 238K | 234K | 229K | 225.82K | 230.79K | 229.86K | 211.53K | 205.11K | 196.04K | 182.79K | 197.56K |
Stock-Based Compensation | 315K | 244K | 965K | 991K | 995K | 1.27M | 1.2M | 1.21M | 1.27M | 1.34M | 1.41M | 1.22M | 1.26M | 1.07M | 1.06M | 1.06M | 1.1M |
Other Working Capital | n/a | 340K | -548K | 1.65M | -1.16M | -475K | -45K | 2.31M | 102K | -2.25M | -1.36M | 151.91K | -1.01M | 1.11M | -1.65M | 2.6M | -1.12M |
Other Non-Cash Items | n/a | 4.35M | 7K | -37K | 1.53M | 2.09M | 17K | 29K | 44K | 55.25K | 47.98K | 48.68K | 352.09K | 78.23K | 1.26M | 54.31K | 54.25K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -2.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.21K | n/a | n/a | n/a |
Change in Working Capital | n/a | 86K | -437K | 1.42M | -1.2M | -795K | 185K | 2.4M | -119K | -2.29M | -1.2M | -702.85K | -600.99K | 1.38M | -1.43M | 2.63M | -1.05M |
Operating Cash Flow | -2.01M | -3.51M | -3.5M | -3.11M | -5.77M | -4.58M | -4.42M | -2.19M | -4.09M | -4.3M | -4.97M | -5.13M | -4.76M | -3.96M | -5.75M | -864.65K | -4.65M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -16K | -202K | n/a | -41.6K | -250.35K | -55.49K | -544.56K | -36.19K | -224.19K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.75 | n/a | 3.74M | n/a | -56.65K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -8.44M | n/a | n/a | n/a | n/a | n/a | n/a | -412 | n/a | -6.99M | -2.49M | -5.41M | -10.66M | -3.05M | -4.08M |
Sales Maturities Of Investments | n/a | 500K | 10.14M | 5M | 2M | 2.96M | 1.1M | 6.4M | 3M | -6M | 6M | 3.25M | 6M | 5.5M | 11.13M | 10.7M | 12.9M |
Other Investing Acitivies | n/a | n/a | 7.94M | -7.94M | 2M | 2.96M | 1.1M | 6.4M | 3M | 6M | 6M | -3.74M | 3.51M | 56.65K | 466.88K | 7.65M | 8.82M |
Investing Cash Flow | n/a | 500K | 9.65M | -2.94M | 2M | 2.96M | 1.08M | 6.2M | 3M | -42.01K | 5.75M | -3.79M | 2.96M | 56.67K | 242.69K | 7.65M | 8.82M |
Debt Repayment | n/a | -1K | -2K | -1K | -1K | -1K | -1K | -1K | -4K | -5K | -3K | -6K | -6K | -5.54K | -8.32K | -8.15K | -7.98K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 800.00 | n/a | n/a | 99K | 13.63K | n/a | 188.63K | 1.21M |
Financial Cash Flow | 1.65M | -1K | -67K | 9.19M | 53K | -1K | -1K | -1K | -4K | -5K | -3K | -6K | 93K | 8.33K | -8.32K | 180.48K | 6.78M |
Net Cash Flow | -360K | -3.01M | 6.08M | 3.15M | -3.72M | -1.62M | -3.34M | 4M | -1.09M | -4.35M | 777.29K | -8.93M | -1.7M | -3.89M | -5.52M | 6.97M | 10.95M |
Free Cash Flow | -2.01M | -3.51M | -3.5M | -3.11M | -5.77M | -4.58M | -4.43M | -2.4M | -4.09M | -4.34M | -5.22M | -5.19M | -5.3M | -3.99M | -5.97M | -864.65K | -4.65M |